Kristen A. Deger

Public health impact of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in the first year of rollout in the United States

Manuela Di Fusco, Kinga Marczell, Kristen A. Deger et al. · Journal of Medical Economics · 2022 · 40 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacoeconomics +17

Health state utilities associated with attributes of migraine preventive treatments based on patient and general population preferences

Louis S. Matza, Kristen A. Deger, Pamela Vo et al. · Quality of Life Research · 2019 · 32 citations · Full text

Pharmacy, Neurology, Health Assessment +16

Outcomes and costs of remote patient monitoring among patients with implanted cardiac defibrillators: An economic model based on the PREDICT RM database

James P. Hummel, Robert J. Leipold, Stacey L. Amorosi et al. · Journal of Cardiovascular Electrophysiology · 2019 · 24 citations · Full text

Pharmacy, Cardiology, Pharmacoeconomics +17

Cost-Effectiveness of Lisocabtagene Maraleucel Versus Axicabtagene Ciloleucel and Tisagenlecleucel in the Third-Line or Later Treatment Setting for Relapsed or Refractory Large B-cell Lymphoma in the United States

Christopher Parker, Fei‐Fei Liu, Kristen A. Deger et al. · Advances in Therapy · 2023 · 17 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17

Health state utilities associated with treatment options for acute myeloid leukemia (AML)

Louis S. Matza, Kristen A. Deger, Timothy A. Howell et al. · Journal of Medical Economics · 2019 · 15 citations

Medicine, Oncology, Pharmacoeconomics +13